Houlihan Lokey Advises ECM, PINOVA Capital, and Gilde Healthcare

Houlihan Lokey is pleased to announce that an investor consortium consisting of funds managed by ECM Equity Capital Management GmbH, PINOVA Capital GmbH, and Gilde Healthcare has acquired a majority stake in DETAX Group (DETAX) as part of a management buyout.

DETAX, founded in 1953 and based in Ettlingen, Germany, is a leading global supplier of biocompatible silicones and light-curing 3D resins for medical applications in the dental and audio sector. As an innovative specialist in medical materials, the group offers its broadly diversified and loyal customer base a high-quality and extensively MDR-certified product portfolio and positions itself as a pioneer in the dynamic environment of 3D printing materials.

Due to its long-standing, strong market positioning and highly innovative strength, DETAX is in an excellent position to leverage such growth. Particularly strong growth potential stems from further internationalisation, new customer acquisitions, as well as active market consolidation. The investor consortium will contribute with its extensive and complementary experience in accompanying growth and internationalisation as well as executing buy-and-build strategies.

Houlihan Lokey provided debt advice on all commercial aspects of the financing transaction and supported the investor consortium on a tailor-made debt financing structure. This financing package provides the group with a balanced offering of attractive terms as well as high flexibility to continue its future growth strategy.